what to do when you plateau on tirzepatide Hit a Tirzepatide: Causes and Solutions Stuck on Semaglutide or Tirzepatide?

Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease

However, adding more compounds increases protocol complexity and makes it harder to track which peptide contributes to specific effects

These tools provide motivation, accountability, and practical guidance that complement clinical care, helping individuals stay engaged and focused on their goals

The study found that while participants lost an average of 14.9% of their body weight, approximately 40% of the mass lost was lean mass (Wilding et al., 2021)